Patheon markets transatlantic cov-lite for DSM merger
Toronto-listed pharmaceuticals firm Patheon is in the market for a $1.15bn-equivalent seven year covenant-lite loan package.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
